My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    BRCA1-mediated repression of select X chromosome genes.

    Jazaeri AA, Chandramouli GV, Aprelikova O, Nuber UA, Sotiriou C, Liu ET, Ropers HH, Yee CJ, Boyd J, Barrett JC.

    J Transl Med. 2004 Sep 21;2(1):32.PMID: 15383145 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.

    Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET.

    J Natl Cancer Inst. 2002 Jul 3;94(13):990-1000.PMID: 12096084 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors.

    Bane AL, Pinnaduwage D, Colby S, Bull SB, O'Malley FP, Andrulis IL.

    Breast Cancer Res Treat. 2009 Sep;117(1):183-91. Epub 2008 Jun 18.PMID: 18563556 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.

    Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer; Australian Ovarian Cancer Study Management Group.

    J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. Epub 2008 Oct 28.PMID: 18957670 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.

    Hosey AM, Gorski JJ, Murray MM, Quinn JE, Chung WY, Stewart GE, James CR, Farragher SM, Mulligan JM, Scott AN, Dervan PA, Johnston PG, Couch FJ, Daly PA, Kay E, McCann A, Mullan PB, Harkin DP.

    J Natl Cancer Inst. 2007 Nov 21;99(22):1683-94. Epub 2007 Nov 13.PMID: 18000219 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.

    Jönsson G, Naylor TL, Vallon-Christersson J, Staaf J, Huang J, Ward MR, Greshock JD, Luts L, Olsson H, Rahman N, Stratton M, Ringnér M, Borg A, Weber BL.

    Cancer Res. 2005 Sep 1;65(17):7612-21.PMID: 16140926 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumors.

    Honrado E, Osorio A, Palacios J, Milne RL, Sánchez L, Díez O, Cazorla A, Syrjakoski K, Huntsman D, Heikkilä P, Lerma E, Kallioniemi A, Rivas C, Foulkes WD, Nevanlinna H, Benítez J.

    J Clin Oncol. 2005 Oct 20;23(30):7503-11.PMID: 16234517 [PubMed - indexed for MEDLINE]Related articles

    8.

    Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.

    Aaltonen K, Blomqvist C, Amini RM, Eerola H, Aittomäki K, Heikkilä P, Nevanlinna H.

    Clin Cancer Res. 2008 Apr 1;14(7):1976-83.PMID: 18381935 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer.

    Pinilla SM, Honrado E, Hardisson D, Benítez J, Palacios J.

    Breast Cancer Res Treat. 2006 Sep;99(1):85-90. Epub 2006 Mar 16.PMID: 16541313 [PubMed - indexed for MEDLINE]Related articles

    10.

    Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors.

    Johannsdottir HK, Jonsson G, Johannesdottir G, Agnarsson BA, Eerola H, Arason A, Heikkila P, Egilsson V, Olsson H, Johannsson OT, Nevanlinna H, Borg A, Barkardottir RB.

    Int J Cancer. 2006 Sep 1;119(5):1052-60.PMID: 16570289 [PubMed - indexed for MEDLINE]Related articles

    11.

    Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables.

    Johannsdottir HK, Johannesdottir G, Agnarsson BA, Eerola H, Arason A, Johannsson OT, Heikkilä P, Egilsson V, Olsson H, Borg A, Nevanlinna H, Barkardottir RB.

    Anticancer Res. 2004 Sep-Oct;24(5A):2681-7.PMID: 15521105 [PubMed - indexed for MEDLINE]Related articles

    12.

    Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.

    Janatova M, Zikan M, Dundr P, Matous B, Pohlreich P.

    Hum Mutat. 2005 Mar;25(3):319.PMID: 15712267 [PubMed - indexed for MEDLINE]Related articles

    13.

    The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors.

    Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL.

    BMC Cancer. 2007 May 19;7:85.PMID: 17511879 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.

    van Beers EH, van Welsem T, Wessels LF, Li Y, Oldenburg RA, Devilee P, Cornelisse CJ, Verhoef S, Hogervorst FB, van't Veer LJ, Nederlof PM.

    Cancer Res. 2005 Feb 1;65(3):822-7.PMID: 15705879 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas.

    Swisher EM, Gonzalez RM, Taniguchi T, Garcia RL, Walsh T, Goff BA, Welcsh P.

    Mol Cancer. 2009 Jul 14;8:48.PMID: 19602291 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.

    Wei M, Grushko TA, Dignam J, Hagos F, Nanda R, Sveen L, Xu J, Fackenthal J, Tretiakova M, Das S, Olopade OI.

    Cancer Res. 2005 Dec 1;65(23):10692-9.PMID: 16322213 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Misbehaviour of XIST RNA in breast cancer cells.

    Sirchia SM, Tabano S, Monti L, Recalcati MP, Gariboldi M, Grati FR, Porta G, Finelli P, Radice P, Miozzo M.

    PLoS One. 2009;4(5):e5559. Epub 2009 May 15.PMID: 19440381 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    No differences in p53 mutation frequencies between BRCA1-associated and sporadic ovarian cancers.

    Aghmesheh M, Nesland JM, Kaern J, Dorum A, Edwards L, Byth K, Friedlander M, Jackson P, Tucker KM, Russell PJ.

    Gynecol Oncol. 2004 Dec;95(3):430-6.PMID: 15581943 [PubMed - indexed for MEDLINE]Related articles

    19.

    Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.

    Walker LC, Waddell N, Ten Haaf A; kConFab Investigators, Grimmond S, Spurdle AB.

    Breast Cancer Res Treat. 2008 Nov;112(2):229-36. Epub 2007 Dec 20.PMID: 18095154 [PubMed - indexed for MEDLINE]Related articles

    20.

    Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells.

    Sirchia SM, Ramoscelli L, Grati FR, Barbera F, Coradini D, Rossella F, Porta G, Lesma E, Ruggeri A, Radice P, Simoni G, Miozzo M.

    Cancer Res. 2005 Mar 15;65(6):2139-46.PMID: 15781624 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk